AMPEL BioSolutions Company
AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.
Founded Date:
2013-07-13
Technology:
Data-driven Technologies
Funding Status:
Seed
Total Funding:
12510000.0
Employee Number:
11-50
Headquarters:
Charlottesville, Virginia, United States
Last Funding Date:
2022-12-13
Investors Number:
1.0
Last Funding Type:
Debt Financing
Estimated Revenue:
$1M to $10M
Industry:
Clinical Development